AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
THE USE OF THE PORT-A-CATH IN CHILDREN WITH HEMOPHILIA - A REVIEW
Authors: VANDENBERG HM FISCHER K ROOSENDAAL G MAUSERBUNSCHOTEN EP
Citation: Hm. Vandenberg et al., THE USE OF THE PORT-A-CATH IN CHILDREN WITH HEMOPHILIA - A REVIEW, Haemophilia, 4(4), 1998, pp. 418-420
TREATMENT PROTOCOLS IN THE NETHERLANDS
Authors: MAUSERBUNSCHOTEN EP ROOSENDAAL G VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., TREATMENT PROTOCOLS IN THE NETHERLANDS, Haemophilia, 4(4), 1998, pp. 428-430
SYNOVIUM IN HEMOPHILIC ARTHROPATHY
Authors: ROOSENDAAL G MAUSERBUNSCHOTEN EP DEKLEIJN P HEIJNEN L VANDERBERG HM VANRINSUM AC LAFEBER FPJG BIJLSMA JWJ
Citation: G. Roosendaal et al., SYNOVIUM IN HEMOPHILIC ARTHROPATHY, Haemophilia, 4(4), 1998, pp. 502-505
A PATIENT WITH ACQUIRED HEMOPHILIA-A AND PEMPHIGUS
Authors: HALBERTSMA FJJ VANDERLINDEN PWG MAUSERBUNSCHOTEN EP
Citation: Fjj. Halbertsma et al., A PATIENT WITH ACQUIRED HEMOPHILIA-A AND PEMPHIGUS, Netherlands journal of medicine, 52(5), 1998, pp. 190-192
VIROLOGICAL RESPONSE IN CHRONIC HCV PATIENTS DURING A 3-YEARS IFN TREATMENT COURSE, COMPARED WITH A 6-MONTH TREATMENT COURSE AND NO TREATMENT
Authors: DAMEN M WEEGINK CJ MAUSERBUNSCHOTEN EP CUYPERS HTM VANDERBERG HM CHAMULEAU RAFM REESINK HW
Citation: M. Damen et al., VIROLOGICAL RESPONSE IN CHRONIC HCV PATIENTS DURING A 3-YEARS IFN TREATMENT COURSE, COMPARED WITH A 6-MONTH TREATMENT COURSE AND NO TREATMENT, Hepatology, 28(4), 1998, pp. 1383-1383
HIGH PREVALENCE OF PARVOVIRUS B19 IGG ANTIBODIES AMONG DUTCH HEMOPHILIA PATIENTS
Authors: MAUSERBUNSCHOTEN EP ZAAIJER HL VANDRIMMELEN AAJ DEVRIES S ROOSENDAAL G VANDENBERG HM LELIE PN
Citation: Ep. Mauserbunschoten et al., HIGH PREVALENCE OF PARVOVIRUS B19 IGG ANTIBODIES AMONG DUTCH HEMOPHILIA PATIENTS, Vox sanguinis, 74(4), 1998, pp. 225-227
HEPATITIS-G VIRUS-RNA AND HEPATITIS-G VIRUS E2 ANTIBODIES IN DUTCH HEMOPHILIA PATIENTS IN RELATION TO TRANSFUSION HISTORY
Authors: MAUSERBUNSCHOTEN EP DAMEN M ZAAIJER HL SJERPS M ROOSENDAAL G LELIE PN CUYPERS HTM VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., HEPATITIS-G VIRUS-RNA AND HEPATITIS-G VIRUS E2 ANTIBODIES IN DUTCH HEMOPHILIA PATIENTS IN RELATION TO TRANSFUSION HISTORY, Blood, 92(6), 1998, pp. 2164-2168
HEPATITIS-G VIRUS (HGV) RNA AND HGV-E2 ANTIBODIES IN DUTCH HEMOPHILIAPATIENTS
Authors: MAUSERBUNSCHOTEN EP DAMEN M ZAAIJER HL ROOSENDAAL G LELIE PN CUYPERS HTM VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., HEPATITIS-G VIRUS (HGV) RNA AND HGV-E2 ANTIBODIES IN DUTCH HEMOPHILIAPATIENTS, Blood, 90(10), 1997, pp. 3317-3317
THE HALF-LIFE OF INFUSED FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A ISINFLUENCED BY ABO BLOOD-GROUP
Authors: VLOT AJ MAUSERBUNSCHOTEN EP ZARKOVA AG HAAN E KRUITWAGEN CLJJ SIXMA JJ VANDENBERG HM
Citation: Aj. Vlot et al., THE HALF-LIFE OF INFUSED FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A ISINFLUENCED BY ABO BLOOD-GROUP, Blood, 90(10), 1997, pp. 690-690
THE INTERNATIONAL-REGISTRY-OF-IMMUNE-TOLERANCE - 1994 UPDATE
Authors: GHIRARDINI A PUOPOLO M CHIAROTTI F MARIANI G BRETTLER DB PEERLINK K BEARDSLEY DS BELL BA BERRETTINI M BLEI F BALLOCCHI A BUTLER R CIAVARELLA N EWING NP FRESSINAUD E GILL J GRINGERI A GROWE GH GUEROIS C HILGARTNER M KASPER CK KISKER CT INWOOD MJ MAGALLON F JOHNSON MM MENZA L MAUSERBUNSCHOTEN EP MILLER RT MORFINI M NAGAO T POON MC RASI V RODEGHIERO F RUBIN SH SCHARRER L SCHIMPF K SCHEIBEL E STRAWCZYNSKY H SULTAN Y THOMPSON AR TUSELL JM WHITE GC SMITH P WALKER I
Citation: A. Ghirardini et al., THE INTERNATIONAL-REGISTRY-OF-IMMUNE-TOLERANCE - 1994 UPDATE, Vox sanguinis, 70, 1996, pp. 42-46
LOW-DOSE IMMUNE TOLERANCE THERAPY - THE VAN CREVELD MODEL
Authors: MAUSERBUNSCHOTEN EP ROOSENDAAL G VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., LOW-DOSE IMMUNE TOLERANCE THERAPY - THE VAN CREVELD MODEL, Vox sanguinis, 70, 1996, pp. 66-67
FORMATION OF ANTIBODIES TO FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A WHO ARE TREATED WITH INTERFERON FOR CHRONIC HEPATITIS-C
Authors: MAUSERBUNSCHOTEN EP DAMEN M REESINK HW ROOSENDAAL G CHAMULEAU RAFM VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., FORMATION OF ANTIBODIES TO FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A WHO ARE TREATED WITH INTERFERON FOR CHRONIC HEPATITIS-C, Annals of internal medicine, 125(4), 1996, pp. 297-299
EFFECT AND SIDE-EFFECTS OF ALPHA-INTERFERON TREATMENT IN HEMOPHILIA PATIENTS WITH CHRONIC HEPATITIS-C
Authors: MAUSERBUNSCHOTEN EP BRESTERS D REESINK HM ROOSENDAAL G CHAMULEAU RAFM HAAN E JANSEN PLM VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., EFFECT AND SIDE-EFFECTS OF ALPHA-INTERFERON TREATMENT IN HEMOPHILIA PATIENTS WITH CHRONIC HEPATITIS-C, Haemophilia, 1(1), 1995, pp. 45-53
RISK OF HEPATITIS-A IN DUTCH HEMOPHILIA PATIENTS
Authors: MAUSERBUNSCHOTEN EP ZAAIJER HL VANDRIMMELEN AAJ VANDENBERG HM ROOSENDAAL G LELIE PN
Citation: Ep. Mauserbunschoten et al., RISK OF HEPATITIS-A IN DUTCH HEMOPHILIA PATIENTS, Thrombosis and haemostasis, 74(2), 1995, pp. 616-618
INHIBITORS WHICH DEVELOPED AFTER EXPOSURE OF HEMOPHILIACS TO A DUTCH PASTEURIZED FACTOR-VIII CONCENTRATE ARE RESTRICTED TO C2-DOMAIN EPITOPES
Authors: VANDENBERG MH MAUSERBUNSCHOTEN EP PRESCOTT R SCANDELLA D
Citation: Mh. Vandenberg et al., INHIBITORS WHICH DEVELOPED AFTER EXPOSURE OF HEMOPHILIACS TO A DUTCH PASTEURIZED FACTOR-VIII CONCENTRATE ARE RESTRICTED TO C2-DOMAIN EPITOPES, Thrombosis and haemostasis, 73(6), 1995, pp. 1027-1027
CARTILAGE DAMAGE AS A RESULT OF INTRAARTICULAR BLEEDINGS IN AN IN-VITRO MODEL FOR HEMOPHILIC ARTHROPATHY
Authors: ROOSENDAAL G VIANEN ME LAFEBER FPJG MAUSERBUNSCHOTEN EP BIJLSMA JWJ VANDENBERG HM
Citation: G. Roosendaal et al., CARTILAGE DAMAGE AS A RESULT OF INTRAARTICULAR BLEEDINGS IN AN IN-VITRO MODEL FOR HEMOPHILIC ARTHROPATHY, Thrombosis and haemostasis, 73(6), 1995, pp. 1037-1037
HEPATITIS-E VIRUS-ANTIBODIES AMONG PATIENTS WITH HEMOPHILIA, BLOOD-DONORS, AND HEPATITIS PATIENTS
Authors: ZAAIJER HL MAUSERBUNSCHOTEN EP TENVEEN JH KAPPRELL HP KOK M VANDENBERG HM LELIE PN
Citation: Hl. Zaaijer et al., HEPATITIS-E VIRUS-ANTIBODIES AMONG PATIENTS WITH HEMOPHILIA, BLOOD-DONORS, AND HEPATITIS PATIENTS, Journal of medical virology, 46(3), 1995, pp. 244-246
HEPATITIS-C INFECTION AND VIREMIA IN DUTCH HEMOPHILIA PATIENTS
Authors: MAUSERBUNSCHOTEN EP BRESTERS D VANDRIMMELEN AAJ ROOSENDAAL G CUYPERS HTM REESINK HW VANDERPOEL CL VANDENBERG HM LELIE PN
Citation: Ep. Mauserbunschoten et al., HEPATITIS-C INFECTION AND VIREMIA IN DUTCH HEMOPHILIA PATIENTS, Journal of medical virology, 45(3), 1995, pp. 241-246
LOW-DOSE IMMUNE TOLERANCE INDUCTION IN HEMOPHILIA-A PATIENTS WITH INHIBITORS
Authors: MAUSERBUNSCHOTEN EP NIEUWENHUIS HK ROOSENDAAL G VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., LOW-DOSE IMMUNE TOLERANCE INDUCTION IN HEMOPHILIA-A PATIENTS WITH INHIBITORS, Blood, 86(3), 1995, pp. 983-988
A POSSIBLE GENETIC-BASIS FOR THE PHARMACOKINETICS OF TRANSFUSED FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A
Authors: VLOT AJ MAUSERBUNSCHOTEN EP HAAN E VANDERSCHOUW YT BOUMA BN SIXMA JJ VANDENBERG HM
Citation: Aj. Vlot et al., A POSSIBLE GENETIC-BASIS FOR THE PHARMACOKINETICS OF TRANSFUSED FACTOR-VIII IN PATIENTS WITH HEMOPHILIA-A, Blood, 86(10), 1995, pp. 3550-3550
TRANSMISSION OF HEPATITIS-C VIRUS TO SPOUSES
Authors: MAUSERBUNSCHOTEN EP BRESTERS D REESINK HW
Citation: Ep. Mauserbunschoten et al., TRANSMISSION OF HEPATITIS-C VIRUS TO SPOUSES, Annals of internal medicine, 122(2), 1995, pp. 154-154
CLINICAL COURSE OF FACTOR-VIII INHIBITORS DEVELOPED AFTER EXPOSURE TOA PASTEURIZED DUTCH CONCENTRATE COMPARED TO CLASSIC INHIBITORS IN HEMOPHILIA-A
Authors: MAUSERBUNSCHOTEN EP ROSENDAAL FR NIEUWENHUIS HK ROOSENDAAL G BRIET E VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., CLINICAL COURSE OF FACTOR-VIII INHIBITORS DEVELOPED AFTER EXPOSURE TOA PASTEURIZED DUTCH CONCENTRATE COMPARED TO CLASSIC INHIBITORS IN HEMOPHILIA-A, Thrombosis and haemostasis, 71(6), 1994, pp. 703-706
COMPARISON OF QUANTITATIVE CDNA-PCR WITH THE BRANCHED DNA HYBRIDIZATION ASSAY FOR MONITORING PLASMA HEPATITIS-C VIRUS-RNA LEVELS IN HEMOPHILIA PATIENTS PARTICIPATING IN A CONTROLLED INTERFERON TRIAL
Authors: BRESTERS D CUYPERS HTM REESINK HW MAUSERBUNSCHOTEN EP VANDENBERG HM SCHAASBERG WP WILBER JC URDEA MS NEUWALD P LELIE PN
Citation: D. Bresters et al., COMPARISON OF QUANTITATIVE CDNA-PCR WITH THE BRANCHED DNA HYBRIDIZATION ASSAY FOR MONITORING PLASMA HEPATITIS-C VIRUS-RNA LEVELS IN HEMOPHILIA PATIENTS PARTICIPATING IN A CONTROLLED INTERFERON TRIAL, Journal of medical virology, 43(3), 1994, pp. 262-268
HEMOPHILIA PROPHYLAXIS IN THE NETHERLANDS
Authors: VANDENBERG HM NIEUWENHUIS HK MAUSERBUNSCHOTEN EP ROOSENDAAL G
Citation: Hm. Vandenberg et al., HEMOPHILIA PROPHYLAXIS IN THE NETHERLANDS, Seminars in hematology, 31(2), 1994, pp. 13-15
AN EPIDEMIC OF INHIBITORS IN MULTITRANSFUSED HEMOPHILIA-A PATIENTS CAUSED BY A PARTICULAR FACTOR-VIII CONCENTRATE
Authors: ROSENDAAL FR NIEUWENHUIS HK VANDENBERG HM HEIJBOER H MAUSERBUNSCHOTEN EP VANDERMEER J SMIT C BRIET E
Citation: Fr. Rosendaal et al., AN EPIDEMIC OF INHIBITORS IN MULTITRANSFUSED HEMOPHILIA-A PATIENTS CAUSED BY A PARTICULAR FACTOR-VIII CONCENTRATE, Thrombosis and haemostasis, 69(6), 1993, pp. 1099-1099
Risultati: 1-25 | 26-32